neuropeptidas
defin
peptidas
activ
brain
enzym
degrad
neuropeptid
peptid
neuromodul
peptid
hormon
found
brain
brain
peptidas
particip
gener
metabol
peptid
protein
addit
possibl
involv
neurotransmiss
neuropeptidas
activ
studi
last
year
emphas
peptidas
pleas
refer
author
former
review
hui
lajtha
neuropeptid
play
import
role
mental
neurolog
diseas
widerlov
wahlestedt
et
al
wide
distribut
central
nervou
system
cn
peripher
nervou
system
serv
neurotransmitt
neuromodul
defici
neuropeptid
exampl
acth
caus
variou
neurolog
sign
sato
et
al
neurophysiolog
abnorm
includ
slow
wave
activ
electroencephalogram
delay
conduct
veloc
peripher
nerv
low
amplitud
muscl
action
potenti
recent
interest
focus
role
neuropeptid
degen
neurolog
diseas
understand
role
could
help
defin
specif
vulner
patholog
process
thu
lead
improv
diagnosi
therapi
abnorm
neuropeptid
neuropeptidas
cn
neuropeptid
costor
catecholamin
especi
norepinephrin
ne
involv
patholog
character
noradrenerg
impair
martignoni
et
al
parkinson
diseas
pd
multipl
system
atrophi
msa
well
central
noradrenerg
deficit
demonstr
dementia
alzheim
type
dat
impair
noradrenerg
transmiss
found
pd
msa
dat
patient
show
signific
reduct
cerebrospin
fluid
csf
neuropeptid
npi
ne
level
martignoni
et
al
huntington
diseas
reduc
concentr
substanc
p
methionineenkephalin
metenk
cholecystokinin
basal
ganglia
contrast
concentr
somatostatin
thyrotrophinreleas
hormon
trh
increas
sagar
et
al
basal
ganglia
neuron
somatostatin
npi
coloc
select
preserv
mark
increas
somatostatin
report
striatum
huntington
chorea
anoth
studi
neurotensin
increas
pallidum
parkinson
diseas
signific
chang
neurotensin
content
observ
palacio
et
al
alzheim
diseas
ad
dementia
associ
parkinson
diseas
concentr
cortic
somatostatin
reduc
jankov
maric
npi
corticotrophinreleas
factor
also
reduc
cerebr
cortex
patient
ad
reduc
cortic
concentr
somatostatin
npi
cerebr
cortex
patient
ad
reflect
loss
neuron
termin
two
peptid
coloc
somatostatin
concentr
reduc
hippocampu
neocortex
patient
die
alzheim
type
dementia
level
trh
gonadotrophinreleas
hormon
neuropeptid
significantli
reduc
patient
senil
dementia
chang
found
telencephal
neurotensin
content
senil
dementia
alzheim
type
sagar
et
al
receptor
neuropeptid
also
chang
neurolog
diseas
mark
reduct
densiti
somatostatin
bind
site
observ
caudat
putamen
patient
huntington
chorea
howev
receptor
well
preserv
nucleu
accumben
ventral
aspect
anterior
putamen
alter
somatostatin
receptor
observ
brain
area
find
suggest
somatostatin
receptor
human
striatum
markedli
downregul
local
popul
neuron
risk
mice
megencephali
due
brain
cell
hypertrophi
exhibit
neurolog
motor
disturb
seizurelik
activ
disturb
insulinlik
growth
factor
system
well
petersson
et
al
enkephalin
messeng
rna
express
upregul
dentat
gyru
granular
layer
ventral
cortic
downregul
pyramid
layer
petersson
et
al
enkephalinlik
immunoreact
elev
mossi
fiber
hippocampu
ventral
cortic
cholecystokinin
regionspecif
upand
downregul
hippocamp
format
increas
level
ventral
cortic
region
galanin
npi
express
increas
sever
layer
interneuron
hippocamp
format
ventral
cortic
well
contrast
galaninlik
immunoreact
reduc
nerv
termin
forebrain
clear
whether
mainli
increas
peptid
level
contribut
excess
growth
brain
repres
consequ
growth
andor
neurolog
motor
disturb
follow
intracerebr
innocul
prion
mice
npi
mrna
express
specif
upregul
pyramid
neuron
wherea
express
hilar
neuron
remain
unalt
neuropeptid
alter
preced
neurolog
dysfunct
neuron
death
play
possibl
role
prion
diseas
diez
et
al
npi
may
regul
glutam
releas
schaffer
synaps
scrapieinfect
mice
lumbar
csf
patient
ad
high
level
neurotensin
detect
martignoni
et
al
good
correl
plasma
csf
argininevasopressin
avp
valu
patient
parkinson
diseas
dementia
cerebrovascular
diseas
multipl
sclerosi
mostli
peripher
neurolog
disord
neuser
et
al
sorensen
et
al
cramer
et
al
vecsei
widerlov
significantli
higher
csfavp
valu
found
patient
cerebrovascular
diseas
wherea
lower
csf
valu
found
patient
dementia
parkinson
diseas
reid
morton
sundquist
et
al
howev
csfplasma
gradient
patient
dementia
parkinson
diseas
decreas
compar
patient
peripher
neurolog
disord
hypoxicischem
encephalopathi
signific
elev
plasma
bendorphin
concentr
neuropeptidas
observ
sankaran
et
al
associ
increas
plasma
bendorphin
concentr
link
ongo
hypoxemia
metenk
leucineenkephalin
leuenk
inhibit
neurolog
sign
markedli
diminish
occurr
intens
histolog
lesion
brain
cervic
thorac
lumbar
spinal
cord
develop
experiment
allerg
encephalomyel
eae
jankov
maric
metenk
potent
immunomodulatorregul
import
pathogenesi
prevent
inflammatori
autoimmun
diseas
nacetylaspartylglutam
naag
neuropeptid
found
millimolar
concentr
brain
local
subpopul
glutamaterg
cholinerg
gabaerg
noradrenerg
neuron
system
naag
releas
upon
depolar
ca
depend
process
agonist
receptor
antagonist
nmethyldaspart
nmda
receptor
naag
exert
neuroprotect
effect
neonat
rat
model
hypoxiaischemia
cai
et
al
effect
larg
associ
activ
receptor
naag
bnaag
protect
injuri
induc
nmda
hypoxia
primari
spinal
cord
cultur
yourick
et
al
vasoact
intestin
peptid
vip
neuropeptid
potent
leuenk
antiinflammatori
effect
protect
inflammatori
disord
neurodegen
disord
includ
multipl
sclerosi
parkinson
diseas
alzheim
diseas
massiv
neuron
cell
death
occur
consequ
uncontrol
inflammatori
respons
vip
also
neuroprotect
effect
inhibit
product
microgliaderiv
proinflammatori
factor
tumor
necrosi
factor
nitric
oxid
prevent
neuron
cell
death
follow
brain
trauma
reduc
inflammatori
respons
neighbor
microglia
vip
thu
valuabl
neuroprotect
agent
treatment
patholog
condit
cn
inflammationinduc
neurodegener
occur
delgado
ganea
trh
induc
neurolog
improv
patient
amyotroph
later
sclerosi
al
littl
none
al
patient
patient
neurolog
diseas
congia
et
al
neurotrop
murin
coronaviru
mhvjhm
jhmv
caus
enceph
paralyticdemyelin
diseas
suscept
strain
mice
rat
congia
et
al
good
model
human
demyelin
diseas
multipl
sclerosi
intracerebr
administr
bendorphin
reduc
incid
jhmvinduc
paralyticdemyelin
diseas
mice
protect
diseas
accompani
significantli
reduc
viru
replic
brain
gilmor
et
al
data
suggest
bendorphin
engag
immun
mechan
host
resist
jhmv
infect
protect
mice
diseas
peptid
deriv
acth
msh
help
postles
repair
mechan
peripher
nervou
system
enhanc
earli
sprout
respons
damag
nerv
peptid
prevent
cisplatin
neuropathi
women
suffer
ovarian
cancer
treatment
base
nonendocrin
fragment
acthmsh
could
therapeut
option
cisplatin
neuropathi
gispen
et
al
mutat
tripeptidyl
peptidas
tppi
recent
associ
lysosom
storag
diseas
late
infantil
neuron
ceroid
lipofuscinosi
tomkinson
junaid
et
al
golabek
et
al
diseas
character
accumul
proteinac
autofluoresc
materi
within
lysosom
neuron
undergo
massiv
cell
death
cours
diseas
warburton
bernardini
wujek
et
al
tppi
requir
partial
complet
digest
certain
neuropeptid
brain
lysosom
dipeptidyl
peptidasei
express
tissu
extens
activ
peptid
compens
loss
tppi
level
naag
activ
carboxypeptidas
ii
alter
region
specif
fashion
sever
neuropsychiatr
disord
coyl
alzheim
postmortem
brain
degrad
increas
brodmann
area
wherea
substanc
p
degrad
increas
tempor
cortex
chang
degrad
neuropeptid
affect
ad
correl
alter
activ
specif
neuropeptidas
trypsinlik
serin
proteas
activ
increas
brodmann
area
ad
parallel
increas
degrad
decreas
activ
neutral
endopeptidas
nep
ec
tempor
cortex
correspond
decreas
degrad
substanc
p
davi
process
age
involv
alter
activ
peptidas
proteas
although
precis
chang
yet
fulli
character
activ
solubl
fraction
prolyl
endopeptidas
reduc
lung
age
anim
water
davi
reduc
activ
solubl
pyroglutamyl
peptidas
aminopeptidas
n
apn
detect
age
kidney
heart
respect
contrast
increas
activ
particul
prolyl
endopeptidas
detect
brain
stem
chang
correl
known
alter
level
peptid
control
enzym
puromycinsensit
aminopeptidas
psa
function
trim
enzym
major
histocompat
complex
mhc
class
pathway
activ
brain
patient
ad
brain
intens
stain
cell
found
rich
cerebr
cortex
doubl
immunofluoresc
studi
confirm
psaposit
cell
reactiv
microglia
psaposit
reactiv
microglia
tend
locat
around
senil
plaqu
observ
associ
neuron
contain
neurofibrillari
tangl
microglia
psa
may
associ
patholog
condit
ad
minnasch
et
al
alanyl
aminopeptidas
activ
lower
csf
patient
ad
wherea
differ
csf
detect
regard
remain
aminopeptidas
chang
found
level
amino
acid
csf
plasma
plasmacsf
ratio
aminopeptidas
activ
higher
patient
ad
although
differ
signific
alanyl
aminopeptidas
iribar
et
al
brain
patient
sporad
ad
decreas
neuron
express
brainspecif
carboxypeptidas
b
cpb
cluster
microglia
peptidas
immunoreact
associ
extracellular
deposit
detect
matsumoto
et
al
brain
cpb
physiolog
function
app
process
may
signific
ad
pathophysiolog
dna
polymorph
angiotensinconvert
enzym
ace
gene
link
risk
late
onset
alzheim
diseas
alvarez
et
al
increas
frequenc
acei
allel
found
patient
ad
distribut
insert
delet
polymorph
ace
patient
ad
associ
ad
ace
genotyp
allel
found
frequenc
ii
genotyp
ad
time
higher
control
dd
genotyp
time
high
alter
distribut
ace
allel
patient
appear
independ
apolipoprotein
e
hu
et
al
condit
medium
cm
nep
antisensetransfect
neuroblastoma
significantli
higher
level
amyloid
b
ab
yamin
et
al
furthermor
synthet
abdegrad
increas
decreas
follow
incub
cm
senseor
antisensetransfect
cell
respect
solubl
ab
degrad
slowli
solubl
ab
aggreg
ab
show
almost
degrad
pretreat
cm
serin
proteinas
inhibitor
complet
inhibit
ab
degrad
addit
serpin
famili
inhibitor
tightli
associ
plaqu
elev
brain
patient
ad
block
ab
degrad
recombin
nep
alon
degrad
ab
cdiisopropyl
fluorophosphateradiolabel
cm
nepoverexpress
cell
contain
increas
level
sever
activ
serin
proteinas
suggest
nep
activ
one
abdegrad
serin
proteas
serpin
inhibitor
neuropeptidas
caus
ab
accumul
inhibit
abdegrad
enzym
direct
bind
ab
render
degrad
resist
insulindegrad
enzym
main
solubl
abdegrad
enzym
neutral
ph
human
brain
highest
ab
proteindegrad
activ
solubl
fraction
occur
ph
aspartyl
proteas
inhibit
pepstatin
synapt
membran
much
lower
ab
proteindegrad
activ
solubl
fraction
edta
inhibit
degrad
activ
inhibitor
nep
ace
aminopeptidas
carboxypeptidas
littl
effect
mcdermott
gibson
novel
zn
depend
metalloproteas
activ
associ
golgi
apparatusand
plasma
membraneenrich
fraction
degrad
endogen
app
gener
ab
contain
ctermin
fragment
proteas
gener
amyloidogen
fragment
app
serv
precursor
ab
mok
et
al
exoand
endopeptidas
involv
breakdown
larger
amino
acid
peptid
smaller
amino
acid
free
amino
acid
distinct
two
group
peptidas
mean
absolut
sinc
endopeptidas
exhibit
exopeptidas
activ
orlowski
enkephalin
endorphin
dynorphin
orphanin
famili
opioid
peptid
found
brain
neurotransmitt
neurohormon
nakanish
et
al
gubler
et
al
boileu
et
al
yoshikawa
et
al
civelli
et
al
molleraeu
et
al
nothack
et
al
hook
reisin
close
structur
relationship
show
consider
overlap
receptormedi
action
analgesia
frenk
et
al
herman
et
al
catalexyepilepsi
frenk
et
al
memori
de
wie
et
al
hypothermia
holaday
et
al
appetit
brand
et
al
morley
sexual
behavior
meyerson
tereniu
hormon
morley
mental
diseas
behavior
cell
function
bloom
et
al
jacquet
mark
recent
involv
enkephalin
pain
percept
behavior
demonstr
transgen
enkknockout
mice
konig
et
al
evalu
signific
neuropeptid
necessari
studi
mechan
underli
control
synapt
format
inactiv
product
endogen
enkephalin
opioid
peptid
requir
proteolyt
process
proenkephalin
pe
take
part
secondari
pathway
product
activ
enkephalin
secret
upon
stimul
enkephalinerg
neuron
pe
enkephalin
belong
opioid
precursor
gene
famili
encod
protein
precursor
whose
proteolyt
product
enkephalin
bendorphin
dynorphin
orphanin
gubler
et
al
proteolyt
process
enzym
requir
gener
activ
opioid
peptid
secret
activ
opioid
receptor
bzdega
et
al
chen
et
al
reinscheid
et
al
noda
et
al
cahil
et
al
king
et
al
przewlocki
przewlocka
suzuki
et
al
enkephalin
neuropeptid
includ
npi
somatostatin
vip
galanin
synthes
precursor
requir
proteolyt
process
pair
basic
residu
gener
activ
peptid
steiner
et
al
hook
et
al
hook
yasothotnsrikul
seidah
et
al
pe
contain
multipl
copi
pentapeptid
metenk
leuenk
enkephalinrel
peptid
figur
pe
requir
proteolyt
process
pair
basic
residu
site
lysarg
argarg
lysli
monobas
arginin
site
well
liber
activ
enkephalin
process
pe
begin
remov
nh
termin
signal
peptid
rough
endoplasm
reticulum
rer
protein
translat
steiner
et
al
hook
et
al
hook
yasothotnsrikul
seidah
et
al
acher
et
al
pe
rout
rer
golgi
apparatu
packag
secretori
vesicl
endopeptidas
cleav
lysarg
pair
basic
residu
site
lysli
argarg
argli
flank
enkephalin
within
precursor
result
peptid
intermedi
contain
basic
residu
extens
coohandor
nh
termini
later
remov
carboxypeptidas
eh
fricker
hook
yasothotnsrikul
arg
ly
aminopeptidas
hook
yasothotnsrikul
yasothornsrikul
et
al
respect
multistep
proteolyt
pathway
gener
bioactiv
enkephalin
figur
four
proteas
consist
cystein
proteas
known
prohormon
thiol
proteas
ptp
yasothornsrikul
et
al
subtilisinlik
prohormon
convertas
azaryan
et
al
aspartyl
proteas
azaryan
et
al
found
use
fulllength
enkephalin
precursor
substrat
krieger
hook
chromaffin
granul
ptp
major
proteas
pecleav
activ
compar
lower
activ
aspartyl
proteas
least
pecleav
activ
hook
eiden
azaryan
et
al
hook
et
al
ptp
show
prefer
process
pe
minim
process
pomc
vitro
azaryan
et
al
schiller
et
al
figur
process
model
proneuropeptid
model
proneuropeptid
contain
one
copi
process
peptid
neurotransmitt
hormon
cleavag
dibas
site
occur
nh
terminu
dibas
residu
cooh
terminu
dibas
residu
site
repres
arrow
posit
respect
remov
basic
residu
coohand
nh
termini
carri
carboxypeptidas
eh
argli
aminopeptidas
respect
figur
ptp
gener
pe
product
vitro
resembl
vivo
ungar
phillip
schiller
et
al
hook
et
al
ptp
cleavag
specif
dibas
monobas
process
site
cleav
within
enkephalincontain
peptid
substrat
nativ
ptp
cleav
pe
enkephalincontain
peptid
substrat
pair
basic
residu
cleavag
site
monobas
arg
site
well
cleavag
specif
ptp
cleavag
nh
termin
side
dibas
residu
site
indic
result
peptid
intermedi
possess
basic
residu
extens
nh
termini
loh
et
al
azaryan
hook
b
azaryan
et
al
studi
pederiv
peptid
demonstr
presenc
enkephalin
peptid
basic
residu
extens
nh
termini
hook
eiden
kreiger
et
al
result
indic
necess
aminopeptidas
remov
arg
ly
residu
nh
termini
peptid
intermedi
one
later
step
pe
process
ptp
fulli
purifi
character
trace
yield
partial
purifi
bovin
medullari
chromaffin
granul
solubl
proteas
glycoprotein
pi
ph
optimum
krieger
hook
thiol
enzym
shown
depend
dithiothreitol
inhibit
phydroxymercuribenzo
mercur
chlorid
cystatin
c
report
ptp
possess
uniqu
nh
termin
primari
sequenc
homolog
known
proteas
tezaosudusm
et
al
howev
work
need
show
ptp
novel
enzym
recent
yasothornsrikul
et
al
report
secretori
vesicl
cathepsin
l
respons
cystein
proteas
chromaffin
granul
convert
pe
activ
enkephalin
peptid
neurotransmitt
yasothornsrikul
et
al
cathepsin
l
activ
identifi
affin
label
activitybas
probe
cystein
proteas
follow
mass
spectrometri
peptid
sequenc
product
metenk
cathepsin
l
occur
proteolyt
process
dibas
monobas
prohormoneprocess
site
coloc
cathepsin
l
metenk
secretori
vesicl
neuroendocrin
chromaffin
cell
shown
immunofluoresc
confoc
immunoelectron
microscopi
cathepsin
l
cosecret
metenk
cathepsin
lgeneknockout
mice
signific
reduct
metenk
level
brain
occur
increas
rel
amount
enkephalin
precursor
yasothornsrikul
et
al
proprotein
convertas
member
mammalian
subtilisinlik
famili
cleav
proinsulin
prohormon
primarili
coohtermin
side
pair
basic
residu
cleavag
nh
termin
side
singl
arginin
residu
peptid
hwang
et
al
ptp
cleav
nh
termin
side
pair
basic
residu
two
basic
residu
wherea
cleav
proopiomelanocortin
pomc
two
basic
residu
coohtermin
side
dibas
residu
proteas
highli
conserv
primari
sequenc
respect
signal
sequenc
proseg
catalyt
domain
p
domain
mammalian
contain
catalyt
triad
residu
asp
ser
bovin
contain
asn
oxyanion
hole
residu
contain
asp
oxyanion
hole
residu
possess
p
domain
function
rrgdl
motif
hwang
et
al
cleavag
specif
process
enzym
requir
carboxypeptidas
eh
aminopeptidas
remov
nh
coohtermin
basic
residu
peptid
intermedi
dhanvantari
et
al
wei
et
al
carboxypeptidas
e
cpe
ec
carboxypeptidas
h
remov
basic
amino
acid
cooh
terminu
peptid
make
biolog
activ
varieti
neuropeptideprocess
endopeptidas
cleav
specif
cleavag
site
cooh
end
basic
residu
gener
intermedi
coohtermin
amino
acid
howev
singl
carboxypeptidas
implic
process
mammalian
neuropeptid
wei
et
al
cpe
present
within
secretori
granul
solubl
form
form
membran
bound
ph
solubl
neutral
ph
fricker
et
al
combin
polar
hydrophob
interact
coohtermin
peptid
appear
respons
revers
phdepend
associ
cpe
membran
silva
et
al
dhanvantari
et
al
arg
metenk
found
isol
bovin
striatum
hui
et
al
structur
purifi
materi
identifi
microsequenc
mass
spectrometri
hexapeptid
argtyrglyglyphemet
nineti
percent
purifi
peptid
arg
metenk
consist
equimolar
met
r
sulfoxid
exist
enkephalin
intermedi
indic
ptp
put
process
enzym
interest
enzym
specif
remov
ntermin
basic
amino
acid
turn
enkephalin
activ
aminopeptidas
activ
neurosecretori
vesicl
convert
arg
metenk
metenk
gainer
et
al
hook
eiden
arginin
aminopeptidas
rap
lysin
aminopeptidas
kap
activ
found
neurosecretori
vesicl
chromaffin
granul
involv
reduc
cysteinyl
residu
major
rapkap
activ
resid
solubl
compon
chromaffin
granul
rather
membran
compon
rap
kap
stimul
nacl
rap
kap
activ
ph
optima
respect
rap
lower
k
enzym
possibl
metalloproteas
inhibit
specif
aminopeptidas
inhibitor
bestatin
amastatin
arphamenin
kap
activ
partial
inhibit
ni
zn
wherea
rap
activ
affect
less
chromaffin
granul
rapkap
resembl
rat
aminopeptidas
b
specif
remov
basic
residu
nh
termini
peptid
recent
found
kap
differ
rap
hui
hui
unpublish
observ
kap
rap
physic
separ
fplc
mono
q
kap
elut
less
nacl
molecular
weight
kap
determin
gelfiltr
dalton
rap
use
aminoacyl
bnaphthylamid
bna
substrat
kap
prefer
lysin
five
time
arginin
rap
prefer
arginin
one
time
lysin
nacl
activ
kap
rap
inhibit
thiol
block
agent
sensit
arphamenin
b
contrast
kap
sensit
bestatin
leukocytederiv
rap
protein
signific
homolog
placent
leucin
aminopeptidas
plap
adipocytederiv
leucin
aminopeptidas
tanioka
et
al
bolumar
et
al
contain
hexxh
x
zincbind
motif
characterist
famili
zinc
metallopeptidas
subfamili
plap
famili
lrap
locat
lumen
side
endoplasm
reticulum
prefer
arginin
synthet
substrat
substrat
specif
restrict
cleav
angiotensin
iii
kallidin
ntermin
extend
precursor
mhc
class
ipres
antigen
peptid
studi
neurotransmitt
enzym
made
substanti
contribut
understand
synapt
biochemistri
inhibitor
turn
valuabl
therapeut
enkephalin
bind
opiat
receptor
neuron
membran
trigger
intracellular
function
action
appar
termin
synapt
degrad
sinc
uptak
intern
mechan
nacetyl
osulf
phosphoryl
glycosyl
found
patey
et
al
goodman
et
al
schwartz
et
al
cn
sever
set
peptidas
capabl
cleav
enkephalin
tyeglyglyphemet
leu
differ
site
aminopeptidas
apn
psa
neuronspecif
aminopeptidas
nap
tyrgli
amid
bond
dipeptidyl
aminopeptidas
dap
glygli
bond
carboxylpeptidas
phemet
bond
ace
nep
glyph
bond
figur
endopeptidas
nep
neprilysin
ec
particip
postsecretori
process
metabol
synapt
releas
neuropeptid
turner
et
al
inhibit
nep
thiorphan
patey
et
al
induc
analgesia
lloren
et
al
controversi
whether
neuron
horsthemk
et
al
barn
et
al
nep
cellsurfac
zinc
metallopeptidas
specif
direct
toward
hydrolysi
peptid
bond
ntermin
side
amino
acid
hydrophob
residu
phe
tyr
leu
trp
turner
barn
hooper
turner
nep
sensit
chelat
agent
edta
highli
suscept
phosphoramidon
k
nm
thiorphan
enzym
distribut
wide
cn
serv
inactiv
enkephalin
tachykinin
somatostatin
turner
et
al
vitro
enzym
hydrolyz
neutrophil
chemotact
peptid
atrial
natriuret
peptid
vasoact
intestin
polypeptid
calcitonin
generel
peptid
nep
found
coloc
plasma
membran
substanc
prich
bouton
substantia
nigra
suggest
probabl
role
neuropeptidas
turner
et
al
molecular
clone
nep
reveal
ident
common
acut
lymphoblast
leukemia
antigen
howel
et
al
impli
primari
role
immun
system
nonetheless
underscor
similar
signal
mechan
interact
immun
nervou
system
ace
ec
peptidyl
dipeptidas
peptidyl
carboxypeptidas
respons
convers
angiotensin
potent
vasoconstrictor
angiotensin
ii
degrad
bradykinin
chai
mendelsohn
hydrolyz
rang
peptid
includ
opioid
peptid
neurotensin
bombesin
tachykinin
lutein
hormonereleas
hormon
chai
mendelsohn
ace
membranebound
ectoenzym
kda
consist
larg
extracellular
domain
transmembran
anchor
small
intracellular
carboxyl
terminu
soubrier
et
al
extracellular
domain
contain
two
region
high
sequenc
homolog
contain
activ
site
sequenc
although
two
site
catalyt
activ
ctermin
one
respons
hydrolysi
angiotensin
bind
inhibitor
wei
et
al
perich
et
al
ntermin
site
structur
constraint
limit
bind
substrat
drug
wei
et
al
human
be
ace
two
form
two
function
testicular
ace
tace
one
activ
site
sequenc
ident
c
terminu
somat
ace
somat
ace
exist
cell
tace
half
size
somat
ace
found
testi
ehler
riordan
perich
et
al
enzym
compos
ahelic
part
incorpor
zinc
ion
two
chlorid
ion
schullenk
wilson
chlorid
ion
activ
tace
interact
substrat
well
howev
structur
tace
place
chlorid
ion
outsid
activ
site
therefor
play
figur
degrad
enkephalin
peptidas
differ
site
nap
neuronspecif
aminopeptidas
apn
aminopeptidas
n
psa
puromycinsensit
aminopeptidas
dap
dipeptidyl
aminopeptidas
ace
angiotensinconvert
endopeptidas
nep
endopeptidas
indirect
role
substrat
activ
wei
et
al
zinc
ion
lie
activ
site
interact
directli
inhibitor
lisinopril
wei
et
al
structur
tace
show
similar
ace
form
found
speci
zinccontain
metallopeptidas
well
testicular
ace
roughli
ellipsoid
shape
divid
two
subdomain
central
groov
activ
site
toward
bottom
groov
cap
ntermin
lid
prevent
larg
molecul
fit
activ
site
somat
ace
consist
two
part
call
nand
cdomain
differ
function
newli
describ
tace
structur
ident
cdomain
structur
somat
ace
serv
templat
search
specif
domainselect
ace
inhibitor
wei
et
al
liber
tyr
major
mode
enkephalin
inactiv
intactcel
cellfre
prepar
hui
lajtha
lentzen
palenk
aminopeptidas
inhibitor
exert
dosedepend
naloxonerevers
analges
effect
administ
mice
zhang
et
al
de
la
baum
et
al
herman
et
al
addit
aminopeptidas
sensit
puromycin
underli
varieti
special
cn
function
memori
herman
et
al
amnesia
eisenstein
et
al
apoptosi
tobler
et
al
schizophrenia
hui
et
al
brain
aminopeptidas
activ
simpli
classifi
psa
gene
depend
psaindepend
puromycinsensit
puromycininsensit
earlier
suggest
enkephalin
bind
opiat
receptor
coupl
subsequ
aminopeptidas
degrad
knight
klee
apn
copurifi
opiat
receptor
hui
et
al
though
apn
later
found
local
exclus
blood
microvessel
solhonn
et
al
mclellan
et
al
aminopeptidas
ec
capabl
liber
variou
amino
acid
residu
nh
termini
peptid
substrat
ubiquit
enzym
mostli
concentr
brain
kidney
classifi
accord
prefer
nh
termin
amino
acid
substrat
locat
suscept
inhibitor
metal
ion
content
residu
link
metal
enzym
ph
maxim
activ
enzym
consid
origin
structur
substrat
specif
specif
locat
depend
physiolog
role
leuenk
readili
hydrolyz
free
tyrosin
glyglypheleu
apn
surfac
microglia
luciu
et
al
apn
activ
microglia
higher
rat
peripher
monocyt
macrophag
sequenc
data
shown
strong
homolog
cellsurfac
glycoprotein
look
et
al
razak
newland
nucleotid
sequenc
predict
integr
membran
protein
singl
hydrophob
segment
near
amino
terminu
aminotermin
protein
sequenc
analysi
molecul
indic
hydrophob
segment
cleav
rather
serv
signal
membran
insert
stabl
membranespan
segment
remaind
molecul
consist
larg
extracellular
carboxytermin
domain
contain
pentapeptid
consensu
sequenc
characterist
member
zincbind
metalloproteas
superfamili
apn
membranebound
glycoprotein
involv
metabol
regulatori
peptid
divers
cell
type
includ
small
intestin
renal
tubular
epitheli
cell
macrophag
granulocyt
synapt
membran
prepar
cell
cn
look
et
al
concentr
psa
highest
brain
mclellan
et
al
apn
solhonn
et
al
eighti
percent
brain
psa
cytosol
use
alabnaphthylamid
substrat
rat
brain
psa
v
max
shown
ph
independ
rang
k
exhibit
pk
neuropeptidas
latter
valu
correspond
pk
amino
group
substrat
use
xala
xleu
examin
specif
site
found
arg
ly
exhibit
highest
affin
follow
met
val
leu
trp
phe
bind
congruent
less
although
k
vari
within
seri
v
max
show
consider
less
variat
significantli
weaker
bind
observ
gli
ala
ser
pro
bind
detect
glu
presenc
p
leu
compar
p
ala
result
approxim
tenfold
decreas
k
littl
chang
v
max
effect
vari
p
residu
examin
seri
leux
case
basic
hydrophob
amino
acid
except
val
exhibit
nearli
k
bind
argarg
lysli
show
k
obtain
argleu
lysleu
respect
leuserph
compar
leuser
p
residu
led
decreas
k
slightli
less
fivefold
increas
v
max
contrast
addit
p
met
leutrp
result
threefold
decreas
k
threefold
increas
v
max
psa
prefer
basic
hydrophob
residu
p
site
subsitesubsit
interact
primarili
affect
bind
johnson
hersh
brain
solubl
membraneassoci
form
psa
tissu
contain
signific
level
solubl
enzym
form
enzym
account
greater
arylamidas
activ
brain
heart
skelet
muscl
contrast
result
obtain
solubl
enzym
form
brain
tissu
found
contain
membraneassoci
enzym
form
brain
membraneassoci
enzym
could
distinguish
membraneassoci
aminopeptidas
activ
tissu
basi
sensit
inhibit
puromycin
mclellan
et
al
membranebound
cytosol
psa
compos
singl
polypeptid
molecular
mass
kda
antisolubl
aminopeptidas
antiserum
react
enzym
form
immunoblot
inhibit
nearli
ident
inhibit
curv
isoelectr
point
pi
two
form
shown
ident
ntermin
sequenc
yield
common
sequenc
pekrpferlptevspini
two
enzym
form
peptid
map
yield
peptid
also
appear
ident
two
enzym
form
membran
form
psa
ident
solubl
enzym
associ
membran
interact
integr
membran
protein
dyer
et
al
membranebound
aminopeptidas
purifi
rat
brain
hui
et
al
enzym
extract
triton
purifi
chromatographi
success
deaesepharos
biogel
htp
sephadex
column
purifi
enzym
show
one
band
disc
gel
electrophoresi
two
band
sodium
dodecyl
sulfat
sd
electrophoresi
molecular
weight
aminopeptidas
ph
optimum
k
mm
v
max
mmolmg
proteinmin
metenk
releas
tyrosin
metenk
split
byproduct
glyglyphemet
hydrolyz
neutral
basic
aminoacyl
bna
gor
bendorphin
dynorphin
enzym
inhibit
specif
aminopeptidas
inhibitor
amastatin
bestatin
bestatingli
subcellular
local
substrat
specif
ph
optimum
molecular
weight
distinguish
leucin
aminopeptidas
aminopeptidas
aminopeptidas
b
aminopeptidas
solubl
aminopeptidas
enkephalin
degrad
psa
inhibit
enkephalincontain
polypeptid
deriv
proenkephalin
proenkephalin
b
proopiomelanocortin
hui
et
al
peptid
arg
metenk
potent
inhibitor
ic
mm
effect
bestatin
inhibit
partli
due
substrat
competit
psa
hydrolyz
arg
metenk
arg
tyr
glyglyphemet
substrateinhibit
manner
hexapeptid
also
inhibit
breakdown
argand
tyrbna
membran
psa
sinc
arg
metenk
inhibit
leucin
aminopeptidas
select
inhibitor
bestatin
metenk
breakdown
aminopeptidas
arg
metenk
also
inhibit
enkephalin
breakdown
synaptosom
plasma
membran
brain
slice
psa
gene
human
psa
gene
compos
exon
intron
span
approxim
kb
chromosom
interv
thompson
et
al
gene
npepp
physic
map
chromosom
use
fluoresc
situ
hybrid
bauer
et
al
psa
homolog
sever
known
zn
bind
aminopeptidas
includ
apn
constam
et
al
analysi
end
human
psa
transcript
reveal
translat
start
site
correspond
nt
human
psa
cdna
comparison
exonexon
boundari
human
psa
gene
human
apn
gene
show
littl
conserv
suggest
two
gene
close
relat
protein
sequenc
diverg
earli
evolut
thompson
et
al
tissu
distribut
psa
polymorph
within
code
region
complet
utr
bauer
et
al
put
catalyt
residu
psa
mutat
result
mutant
enzym
app
exhibit
normal
catalyt
activ
app
exhibit
decreas
substrat
bind
app
exhibit
decreas
substrat
bind
catalysi
app
app
analyz
respect
transitionst
inhibitor
bind
effect
seen
mutat
app
exhibit
lower
affin
transitionst
inhibitor
thu
involv
transitionst
stabil
convers
glutam
glutamin
result
reduct
catalyt
activ
convers
residu
alanin
caus
decreas
activ
glutam
valin
mutat
dramat
reduc
catalyt
activ
contrast
dramat
effect
catalysi
three
mutat
produc
rel
small
effect
substrat
bind
affin
mutat
conserv
tyrosin
phenylalanin
result
decreas
k
cat
littl
effect
bind
glutam
act
gener
acidbas
catalyst
mutat
convert
enzym
inact
bind
protein
effect
mutat
tyrosin
consist
involv
residu
transitionst
stabil
homozyg
goku
mice
gener
genetrap
mutat
show
dwarfism
mark
increas
anxieti
analges
effect
osada
et
al
function
psa
disrupt
transcript
arrest
psa
gene
drastic
decreas
aminopeptidas
activ
psa
gene
strongli
express
brain
especi
striatum
hippocampu
psa
gene
requir
normal
growth
behavior
associ
anxieti
pain
osada
et
al
patient
schizophrenia
prefront
cingul
frontal
cortic
thalamu
hippocampu
hypothalamu
outer
globu
pallidu
contain
significantli
less
psa
quantifi
western
blot
analysi
correspond
area
control
subject
hui
et
al
aminopeptidas
may
play
import
role
process
toler
withdraw
associ
morphin
administr
increas
activ
psa
found
brain
cortex
heroin
addict
human
larrinaga
et
al
rat
treat
morphin
activ
solubl
psa
found
higher
frontal
cortex
irazusta
et
al
contrast
rat
experienc
withdraw
symptom
present
decreas
level
aminopeptidas
activ
certain
brain
area
activ
apn
hippocampu
solubl
psa
frontal
cortex
lower
rat
experienc
naloxoneprecipit
withdraw
symptom
howev
activ
aminopeptidas
vitro
unalt
incub
morphin
suggest
indirect
action
opioid
upon
aminopeptidas
psa
particip
proteolyt
event
essenti
cell
growth
viabil
constam
et
al
proteolysi
involv
cascad
enzym
includ
proteasom
psa
local
cytoplasm
nucleu
associ
microtubul
spindl
apparatu
mitosi
puromycin
bestatin
arrest
cell
cycl
lead
accumul
cell
phase
ultim
induc
cell
undergo
apoptosi
concentr
inhibit
psa
psa
develop
psa
activ
increas
twofold
synaptosom
mitochondri
fraction
period
axon
dendrit
growth
enzym
also
signific
agerel
chang
nuclear
fraction
signific
development
chang
apn
found
myelin
microsom
fraction
less
signific
found
psa
de
gandaria
et
al
psa
mainli
transport
anterograd
axon
flow
play
role
metabol
neuropeptid
nerv
termin
synapt
cleft
yamamoto
et
al
strong
aminopeptidas
activ
found
cn
neuron
cell
bodi
use
histochemistri
situ
hybrid
constam
et
al
synaps
channel
commun
neuron
site
storag
inform
encod
gene
experiencememori
nerv
termin
site
integr
signal
receiv
modifi
secretori
respons
action
potenti
releas
neuropeptid
neurotransmitt
final
respons
nerv
excitatori
inhibitori
input
converg
upon
site
final
signal
output
nerv
termin
especi
sensit
critic
point
control
neuron
understand
modif
occur
studi
neuropeptid
metabol
nerv
termin
present
neural
anchor
deciph
brain
work
anatom
distribut
specif
locat
associ
limit
substrat
specif
constitut
function
specif
would
interest
find
aminopeptidas
specif
cn
synaps
neuron
shaw
cook
knowledg
specif
enkephalininactiv
aminopeptidas
facilit
understand
neuropeptid
function
synaps
wide
distribut
aminopeptidas
brain
possess
overlap
substrat
specif
order
quantifi
accur
aminopeptidas
biolog
sampl
postcolumn
continuousflow
aminopeptidas
detector
develop
hui
hui
conjug
fplc
provid
fast
sensit
specif
reliabl
method
brain
aminopeptidas
screen
quantit
enzym
interest
separ
interf
peptidas
activ
endogen
inhibitor
sampl
hui
hui
use
leucin
bnaphthylamid
leu
bna
substrat
two
novel
neuronspecif
enkephalindegrad
aminopeptidas
separ
psa
fplc
mono
q
figur
present
mammalian
cn
peripher
tissu
serum
sciatic
nerv
tabl
two
aminopeptidas
present
exclus
neuron
nerv
cell
neuroblastoma
region
distribut
differ
highest
found
hippocampu
wherea
highest
colliculu
hypothalamu
highest
ratio
aminopeptidas
enrich
synaptosom
rat
brain
solubl
rest
associ
membran
despit
relationship
establish
hui
et
al
higher
synaptosom
lysat
specif
activ
cytosol
fraction
membran
fraction
rat
cerebrocort
neuron
cultur
activ
total
aminopeptidas
activ
cerebellar
granul
cell
absent
astrocyt
found
glioma
c
neuroblastoma
figur
zymogram
aminopeptidas
fplcaminopeptidas
analyz
sknsh
cell
predomin
brain
synaptosom
suggest
play
signific
role
neurotransmiss
synapt
differenti
purif
character
nap
purifi
rat
brain
homogen
ammonium
sulfat
fraction
follow
column
chromatographi
success
phenylsepharos
sephadex
twice
mono
q
fplc
hui
et
al
purifi
singlechain
enzym
estim
kda
pi
ph
optimum
mg
restor
activ
apoenzym
neutral
aminopeptidas
hydrolyz
bna
amino
acid
aliphat
polar
uncharg
posit
charg
aromat
side
chain
km
mm
k
cat
metenk
releas
ntermin
tyrosin
thioldepend
metalloenzym
sensit
amastatin
inhibit
k
mm
aminopeptidas
sensit
puromycin
properti
differ
ubiquit
psa
obtain
enzym
prepar
block
n
terminu
substrat
inhibitor
specif
hydrolyt
coeffici
metal
effect
pi
molecular
weight
catalyt
site
show
enzym
distinct
known
aminopeptidas
hui
et
al
use
antipsa
igg
screen
rat
brain
cdna
express
librari
cdna
isol
probe
cdna
clone
candid
cdna
ident
mous
psa
encod
ntermin
section
neural
aminopeptidas
nucleotid
segment
posit
homolog
posit
psa
ident
contain
sequenc
encod
dival
metalbind
motif
hexxh
x
e
aminopeptidas
shannon
et
al
sequenc
end
ident
psa
novel
void
sequenc
encod
univers
ntermin
penkrpferlptevspini
psa
dyer
et
al
constam
et
al
tobler
et
al
block
ntermin
residu
though
wait
identifi
clone
data
impli
purifi
enzym
uniqu
aminopeptidas
possibl
member
psa
superfamili
neuron
growth
found
rat
hippocampu
age
hui
hui
lower
immatur
rat
embryonicday
fetu
contain
least
increas
steepli
prenat
earli
postnat
period
ninefold
first
month
rate
increas
diminish
subsequ
increas
second
month
third
agedepend
increas
activ
parallel
protein
express
specif
hydrolyt
antigen
newborn
respect
growth
profil
distinct
psa
similar
differ
also
found
develop
primari
cerebellar
granul
cell
puromycin
mm
block
neurit
outgrowth
caus
apoptosi
nonantibiot
effect
figur
found
inhibitor
releas
electr
stimul
slice
brain
kidney
liver
five
hippocamp
tissu
slice
mg
mm
thick
rins
equilibr
perfus
kreb
solut
mlmin
microvolum
ml
glass
chamber
perfus
effluent
mix
figur
flow
rate
mlmin
join
leu
bna
mlmin
enzym
reaction
proceed
delay
coil
c
min
detect
releas
bnaphthylamid
fluoresc
inhibitor
activ
monitor
continu
measur
decreas
free
bnaphthylamid
inhibitor
releas
electr
stimul
optim
condit
neuropeptid
releas
hz
shock
milusheva
et
al
figur
show
typic
trace
activ
inhibit
electr
stimuli
brain
slice
stimulu
inhibitori
effect
independ
intens
v
frequenc
hz
observ
potenc
releas
inhibitor
stimulu
equival
nmol
bestatin
potent
inhibit
due
substrat
mm
leu
bna
competit
due
neither
serotonin
catecholamin
acetylcholin
amino
acid
metenk
inhibitori
effect
perfus
show
effect
figur
flow
diagram
autom
analyz
nap
inhibitor
releas
tissu
slice
figur
synapt
aminopeptidas
activ
inhibit
factor
releas
electr
stimul
hippocamp
slice
radioreceptor
bind
k
site
indic
inhibit
enkephalin
enkephalinlik
peptid
ninhydrinposit
inhibitor
could
retain
reversephas
c
seppak
column
elut
methanol
activ
disappear
treatment
hcl
c
hr
data
indic
smallpeptid
inhibitor
vesicul
synaps
inhibitor
estim
dalton
sephadex
peptidas
protein
degrad
essenti
life
death
everi
cell
protein
broken
constitut
amino
acid
success
peptidas
lysosom
cytosol
tppi
tppii
enzym
count
three
releas
ntermin
tripeptid
oligopeptid
gener
differ
endopeptidas
tripeptid
degrad
exopeptidas
releas
amino
acid
dipeptid
molecular
weight
tppi
calcul
nondenatur
polyacrylamid
electrophoresi
page
gel
filtrat
respect
sdspage
absenc
presenc
bmercaptoethan
respect
enzym
compos
six
ident
subunit
human
tppi
five
potenti
nglycosyl
site
asn
residu
dual
role
oligosaccharid
fold
lysosom
target
could
contribut
unusu
cell
typedepend
fate
misfold
tppi
conform
repres
molecular
basi
diseas
process
subject
natur
occur
missens
mutat
wujek
et
al
although
tppi
zymogen
capabl
autoactiv
vitro
serin
proteas
sensit
aebsf
particip
process
proenzym
matur
activ
form
vivo
golabek
et
al
tppi
inhibit
pcmb
dfp
hgcl
exotyp
serin
peptidas
regul
sh
reagent
tppi
releas
tripeptid
argvaltyr
angiotensin
iii
rapidli
alaalaphemca
also
releas
glyasnleu
neuromedin
b
veloc
alaalaphemca
du
et
al
tppi
degrad
small
peptid
extend
ntermin
domain
structur
peptid
gener
cut
occur
mass
kda
refer
structur
peptidas
suggest
mechan
size
select
bernardini
warburton
order
tppi
mrna
express
follow
kidney
liver
heart
brain
lung
spleen
skelet
muscl
testi
du
et
al
tppi
larg
respons
degrad
sulfat
enter
cell
receptormedi
endocytosi
cell
surfac
wherea
tppii
respons
regul
extracellular
level
breslin
et
al
tppii
ec
serin
peptidas
appar
involv
inactiv
cholecystokinin
octapeptid
rose
et
al
tppii
mostli
detect
neuron
also
ependym
cell
choroid
plexus
local
consist
possibl
particip
peptidas
inactiv
cholecystokinin
circul
csf
also
detect
ultrastructur
level
cerebr
cortex
hypothalamu
peptidas
mainli
associ
cytoplasm
neuron
somata
dendrit
often
vicin
reticulum
cisterna
golgi
apparatu
vesicl
inner
side
dendrit
plasma
membran
facchinetti
et
al
naag
catabol
nacetylaspart
glutam
primarili
glutam
carboxypeptidas
ii
naaladas
express
extracellular
surfac
astrocyt
naaladas
clone
human
brain
luthicart
et
al
rat
brain
cdna
luthicart
et
al
rat
hippocamp
cdna
librari
bzdega
et
al
naaladas
inhibit
prevent
cocainekindl
seizur
witkin
et
al
roja
et
al
naaladas
inhibitor
phosphonomethyl
pentanedio
acid
produc
dosedepend
protect
mgkg
develop
seizur
neuropeptidas
kindl
occurr
seizur
kindl
process
without
observ
behavior
side
effect
thoma
et
al
inhibit
also
protect
motor
neuron
death
famili
amyotroph
later
sclerosi
model
ghadg
et
al
bestatininsensit
aminopeptidas
bia
thiol
aminopeptidas
resist
puromycin
bestatin
inhibit
neidl
et
al
unpublish
observ
purifi
homogen
rat
brain
cytosol
bia
separ
aminopeptidas
b
apb
psa
isol
deae
chromatographi
molecular
weight
kda
compos
six
subunit
releas
tyr
enkephalin
dipeptid
enzym
inhibit
heavi
metal
ion
thiolbind
reagent
includ
leupeptin
aminopeptidas
readili
differenti
enzym
partial
overlap
specif
leucin
aminopeptidas
aminopeptidas
b
n
psa
resist
inhibit
bestatin
metalchel
agent
therapeut
use
neuropeptidas
inhibitor
ace
inhibit
reduc
morbid
mortal
patient
hypertens
diabet
mellitu
atherosclerosi
heart
failur
nephropathi
ace
inhibitor
could
use
manag
wide
rang
cardiovascular
patholog
stanton
patient
risk
cardiovascular
event
normal
left
ventricular
function
demonstr
clear
benefit
ace
inhibitor
patient
chronic
left
ventricular
dysfunct
postmyocardi
infarct
show
reduct
ischem
event
stanton
use
ace
inhibitor
treat
hypertens
indic
neuropeptidas
make
good
drug
target
docherti
et
al
genom
research
yield
mani
possibl
new
drug
target
neuropeptidas
causal
respons
diseas
process
might
therefor
make
better
target
especi
lead
develop
drug
administ
oral
besid
inhibitor
antibodi
peptidas
also
use
therapeut
inhibit
aminopeptidas
nep
bestatin
thiorphan
exert
strong
longlast
analgesia
termin
cancer
patient
similar
effect
found
two
activ
inhibitor
acetorphan
carbaphethiol
nobl
roqu
kelatorphan
mix
inhibitor
psa
apn
nep
dap
activ
morphin
mani
test
thorsett
wyvratt
anoth
mix
inhibitor
phelorphan
affect
morphin
withdraw
syndrom
van
amsterdam
et
al
oral
activ
nep
inhibitor
produc
analgesia
mice
alter
gastrointestin
movement
respiratori
function
chipkin
et
al
addit
inact
test
measur
potenti
antianxieti
antidepress
antipsychot
effect
demonstr
inhibitor
specif
pharmacolog
effect
opiat
sinc
enkephalinerg
pathway
analgesia
uniqu
feasibl
nap
inhibitor
may
nonaddict
analges
without
psychotrop
side
effect
revers
irrevers
inhibitor
aminopeptidas
design
small
stabl
higher
affin
bloodbrain
barrier
permeabl
tieku
hooper
revers
mercaptoethylamin
hydrophob
side
chain
potent
dentat
inhibitor
apn
picker
et
al
revers
carbaphethiol
parenter
activ
form
phethiol
also
develop
structur
featur
necessari
interact
mercaptoamin
aminopeptidas
specif
aminopeptidas
contain
subsit
contribut
specif
substrat
bind
r
group
ntermin
amino
acid
r
group
peptid
chain
bryce
rabin
van
amsterdam
et
al
irrevers
inhibitor
resist
metabol
inactiv
greater
valu
vivo
studi
diazomethyl
keton
specif
attack
activ
site
cystein
residu
fujiwara
et
al
shown
extraordinarili
potent
inhibitor
pyroglutamyl
aminopeptidas
wilk
et
al
highli
effect
vivo
studi
low
toxic
substitut
function
group
synthet
compound
potent
select
inhibitor
enk
inactiv
may
becom
avail
natur
avail
inhibitor
frequent
higher
select
potenc
synthet
one
snake
venom
peptid
inhibitor
play
crucial
role
establish
clinic
valu
capoten
hypertens
microbi
inhibitor
shown
highli
activ
spectrum
peptidas
proteinas
wilk
et
al
discoveri
phosphoramidon
nep
inhibitor
help
develop
novel
inhibitor
kenni
interest
abovement
synthet
natur
inhibitor
modifi
peptid
umezawa
umezawa
aoyagi
recent
one
potent
ace
inhibitor
design
converstatin
character
tryptic
fragment
plasma
protein
k
valu
picomolar
rang
okuda
arakawa
peptid
inhibitor
enkephalinas
would
superior
nontox
rapaka
metabol
amino
acid
caus
liver
kidney
damag
opiat
inhibitor
cerebr
peptidas
cross
placent
barrier
addit
advantag
use
analges
pregnant
women
arg
metenk
purifi
character
endogen
psa
inhibitor
calf
striatum
hui
et
al
like
addit
possibl
role
opioid
enkephalincontain
polypeptid
may
regul
enkephalin
level
hui
et
al
hui
et
al
potent
one
stronger
bestatin
puromycin
hui
et
al
hui
et
al
inhibitor
inactiv
specif
enzym
dapv
specif
releas
ntermin
argtyr
hui
although
nap
sensit
smallpeptid
inhibit
vitro
substrat
inhibitor
specif
differ
psa
hui
et
al
arg
metenk
degrad
new
type
dap
enzym
purifi
recoveri
rat
brain
membran
column
chromatographi
success
cellux
argtyrahsepharos
hydroxylapatit
sephadex
membran
solubil
nonidet
hui
enzym
activ
assay
hplc
use
arg
metenk
substrat
presenc
bestatin
thiorphan
captopril
sdspage
purifi
enzym
appar
homogen
molecular
weight
dalton
thiol
enzym
optim
activ
ph
select
activ
mn
co
zn
split
arg
metenk
equal
amount
argtyr
glyglyphemet
k
mm
v
max
mmolmg
protein
per
min
dap
hydrolyz
model
substrat
dapi
dapii
dapiii
dapiv
amino
acid
bna
actin
desmin
tubulin
glial
fibrillari
acid
protein
cytoskeleton
neurofila
protein
enzym
insensit
puromycin
inhibit
sever
neruropeptid
angiotensin
iii
potent
k
mm
substrat
specif
ph
optimum
molecular
weight
activ
catalyt
site
demonstr
enzym
distinct
dap
neuropeptidas
presynapt
enk
cross
synapt
cleft
act
dendrit
axon
neuron
perikarya
pasquini
et
al
bloodborn
enk
indic
peptid
receptor
distant
synaps
travel
attack
peptidas
unavoid
recent
find
indic
pharmacolog
effect
puromycin
bestatin
thiorphan
due
protect
enk
destruct
receptor
bind
inhibit
postsynapt
peptidas
bestatin
thiorphan
increas
releas
enk
k
stimul
patey
et
al
indic
peptidas
inhibitor
play
major
regulatori
role
process
physiolog
function
insulin
control
degrad
releas
neuron
halban
presynapt
regul
allow
neuron
store
releas
peptid
rel
independ
axoplasm
transport
believ
enk
neurotransmitt
alik
constantli
releas
basal
level
increas
stimul
continu
produc
high
level
degrad
product
degrad
inhibit
stimul
releas
inhibitor
releas
togeth
enk
synapt
cleft
inde
enk
coreleas
peptid
winkler
et
al
nap
inhibitor
releas
rat
hippocamp
slice
electr
stimul
enzym
found
sensit
smallpeptid
solubl
fraction
extract
bovin
brain
hui
hui
unpublish
observ
studi
synapt
peptidas
endogen
inhibitor
import
theoret
practic
point
view
first
enabl
design
inhibitor
relev
peptidas
may
mimic
larg
extent
effect
exogen
opioid
second
inhibitor
may
potenti
enk
biolog
action
therebi
contribut
delin
function
role
addit
provid
new
insight
regulatori
mechan
peptid
neurotransmiss
live
brain
lead
develop
novel
inhibitor
innov
analges
without
unwant
side
effect
experienc
narcot
neuropeptidas
play
critic
role
biosynthesi
metabol
neuropeptid
crucial
health
abnorm
neuropeptidas
found
numer
mental
degen
neurolog
diseas
opioid
peptid
enkephalin
well
studi
neuropeptid
synthes
group
peptidas
act
orderli
sequenc
contrast
inactiv
enkephalin
like
control
singl
peptidasenap
studi
neuropeptidas
broaden
knowledg
nervou
system
function
ultim
lead
develop
better
diagnosi
treatment
target
gene
enzym
level
mental
neurolog
diseas
therapeut
develop
approach
safer
effici
cost
effect
